Patents Assigned to BIOCELLCHALLENGE
  • Amphiphilic derivatives of triazamacrocyclic compounds, products and compositions including same, and synthesis methods and uses thereof
    Patent number: 9822083
    Abstract: The invention relates to amphiphilic derivatives of a triazamacrocyclic compound, as well as to said derivatives as active molecule transporters. The invention also relates to a nanodrug including at least one amphiphilic derivative of a triazamacrocyclic compound and at least one active molecule of a protein such as an antibody, in particular for the treatment of autoimmune diseases or for the treatment of cancer.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: November 21, 2017
    Assignee: BIOCELLCHALLENGE
    Inventors: Stéphane Moutard, Vincent Delauzun, Laurent Meunier
  • AMPHIPHILIC DERIVATIVES OF TRIAZAMACROCYCLIC COMPOUNDS, PRODUCTS AND COMPOSITIONS INCLUDING SAME, AND SYNTHESIS METHODS AND USES THEREOF
    Publication number: 20170035886
    Abstract: The invention relates to amphiphilic derivatives of a triazamacrocyclic compound, as well as to said derivatives as active molecule transporters. The invention also relates to a nanodrug including at least one amphiphilic derivative of a triazamacrocyclic compound and at least one active molecule of a protein such as an antibody, in particular for the treatment of autoimmune diseases or for the treatment of cancer.
    Type: Application
    Filed: October 19, 2016
    Publication date: February 9, 2017
    Applicant: BIOCELLCHALLENGE
    Inventors: Stéphane Moutard, Vincent Delauzun, Laurent Meunier
  • AMPHIPHILIC DERIVATIVES OF TRIAZAMACROCYCLIC COMPOUNDS, PRODUCTS AND COMPOSITIONS INCLUDING SAME, AND SYNTHESIS METHODS AND USES THEREOF
    Publication number: 20150353514
    Abstract: The invention relates to amphiphilic derivatives of a triazamacrocyclic compound, as well as to said derivatives as active molecule transporters. The invention also relates to a nanodrug including at least one amphiphilic derivative of a triazamacrocyclic compound and at least one active molecule of a protein such as an antibody, in particular for the treatment of autoimmune diseases or for the treatment of cancer.
    Type: Application
    Filed: January 21, 2014
    Publication date: December 10, 2015
    Applicant: BIOCELLCHALLENGE
    Inventors: Stéphane Moutard, Vincent Delauzun, Laurent Meunier